ArticleBMJ (Clinical research ed.)2022

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.